Featured Article
Testing new radiotherapy techniques for breast cancer
Refining the intensity modulated radiotherapy technique.
Report reveals year of research success
02 Feb 2012
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have launched their Joint Annual Research Report for 2010/11, highlighting a year of significant achievements.
Prostate cancer drug shows impressive new Phase III trial results
01 Feb 2012
Patients with advanced prostate cancer who were given a new type of hormonal treatment called MDV3100 lived an extra 4.8 months compared to men taking a placebo, according to the full analysis of a Phase III trial.
Women with faulty BRCA genes more likely to survive ovarian cancer
24 Jan 2012
Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association.
Musculoskeletal side–effects from breast cancer treatment not long term
20 Jan 2012
A drug regimen found to cut a women’s risk of dying from breast cancer gives a higher risk of carpal tunnel syndrome, but this can be managed and does not persist once treatment has finished.
See 2012 Press Release Archive |
